We are live on ! Find out more
BA

Bennicas & Associates Portfolio holdings

AUM $173M
1-Year Est. Return 1.55%
This Fund
S&P 500
This Quarter Est. Return
+5.35%
1 Year Est. Return
+1.55%
3 Year Est. Return
+40.28%
5 Year Est. Return
+86.07%
10 Year Est. Return
AUM
$129M
AUM Growth
+$9.22M
Cap. Flow
+$3.27M
Cap. Flow %
2.53%
Top 10 Hldgs %
40.83%
Holding
83
New
Increased
12
Reduced
26
Closed

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$110K
2
CPRT icon
Copart
CPRT
+$62.1K
3
CLX icon
Clorox
CLX
+$15.8K
4
CSX icon
CSX Corp
CSX
+$14K
5
DNP icon
DNP Select Income Fund
DNP
+$13.9K

Sector Composition

Rank Sector Weight
1 Consumer Staples 24.52%
2 Healthcare 13.63%
3 Materials 11.59%
4 Technology 8.8%
5 Real Estate 8.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAAS icon
26
Pan American Silver
PAAS
$17.9B
$1.75M 1.35%
111,269
+3,500
+3% +$56.6K
SO icon
27
Southern Company
SO
$108B
$1.73M 1.34%
28,050
CVX icon
28
Chevron
CVX
$382B
$1.65M 1.27%
13,882
LLY icon
29
Eli Lilly
LLY
$1.08T
$1.61M 1.25%
14,402
+57
+0.4% +$6.35K
LMT icon
30
Lockheed Martin
LMT
$131B
$1.52M 1.18%
3,890
UL icon
31
Unilever
UL
$142B
$1.51M 1.17%
22,280
-89
-0.4% -$6.17K
KMB icon
32
Kimberly-Clark
KMB
$37.6B
$1.49M 1.16%
10,500
BMY icon
33
Bristol-Myers Squibb
BMY
$129B
$1.47M 1.14%
28,975
ABT icon
34
Abbott
ABT
$187B
$1.47M 1.14%
17,543
GRX
35
Gabelli Healthcare & Wellness Trust
GRX
$145M
$1.43M 1.11%
137,500
K
36
DELISTED
Kellanova
K
$1.4M 1.09%
23,244
-159
-0.7% -$9.09K
GILD icon
37
Gilead Sciences
GILD
$165B
$1.36M 1.05%
21,400
-150
-0.7% -$9.8K
RTX icon
38
RTX Corp
RTX
$290B
$1.29M 1%
14,999
VZ icon
39
Verizon
VZ
$197B
$1.28M 1%
21,292
-200
-0.9% -$11.5K
T icon
40
AT&T
T
$164B
$1.28M 0.99%
44,702
+2,118
+5% +$56.1K
SNY icon
41
Sanofi
SNY
$107B
$1.24M 0.96%
26,709
TTE icon
42
TotalEnergies
TTE
$193B
$1.17M 0.9%
22,450
+1,500
+7% +$77.8K
JNJ icon
43
Johnson & Johnson
JNJ
$640B
$1.09M 0.85%
8,450
WY icon
44
Weyerhaeuser
WY
$17.6B
$1.08M 0.84%
39,066
DNP icon
45
DNP Select Income Fund
DNP
$4.14B
$950K 0.74%
73,851
-1,125
-2% -$13.9K
AEM icon
46
Agnico Eagle Mines
AEM
$72.2B
$906K 0.7%
16,900
-100
-0.6% -$5.67K
AAPL icon
47
Apple
AAPL
$4.97T
$851K 0.66%
15,192
-100
-0.7% -$5.23K
DOC icon
48
Healthpeak Properties
DOC
$15.5B
$822K 0.64%
23,074
-400
-2% -$13.5K
BG icon
49
Bunge Global
BG
$20.9B
$818K 0.63%
14,450
PFE icon
50
Pfizer
PFE
$143B
$793K 0.61%
23,267

Similar funds

Bennicas & Associates's Q3 2019 Portfolio in Review

As of Q3 2019, Bennicas & Associates held 83 positions worth $129M, up 7.7% from $120M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 0%. Bennicas & Associates opened no new positions and made no exits, leaving the 83-position portfolio largely intact.

By sector, the portfolio is most concentrated in Consumer Staples at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Materials.

  • Bennicas & Associates added most to AbbVie in Q3 2019, an estimated $2.74M increase.
  • Bennicas & Associates's biggest Q3 2019 reduction was Oracle, cutting an estimated $110K.
  • Bennicas & Associates's ten largest holdings make up 41% of its $129M portfolio in Q3 2019.
  • Bennicas & Associates opened 0 new positions and closed 0 in Q3 2019.
  • Bennicas & Associates's portfolio value rose 7.7% quarter-over-quarter to $129M.

Based on Bennicas & Associates's 13F filing for Q3 2019, filed 7 Oct 2019.